- Latest week
- 17 Jul 2026
- Close
- 22.592501
- Fair value
- 19.943131
- Next-week expectancy
- Undecided 54.67%
CURE Chart Pack
VanEck Genomics and Healthcare Innovators UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, CURE rose 12.85%, moving from 20.02 to 22.59. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -1.30 and has improved across the 12-week window. Market Dynamics is 1.14 on the latest week. Next-week expectancy is undecided at 54.66% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 22.59
- 12-Week Change
- 12.85%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 54.66%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -1.30
- Market Dynamics
- 1.14
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 22.59
- 12-Week Change
- 12.85%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 54.66%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -1.30
- Market Dynamics
- 1.14
Over the latest 12 completed weeks ending 2026-07-17, CURE rose 12.85%, moving from 20.02 to 22.59. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -1.30 and has improved across the 12-week window. Market Dynamics is 1.14 on the latest week. Next-week expectancy is undecided at 54.66% based on similar historical setup states.